n-vinyl-2-pyrrolidinone has been researched along with Coronary Disease in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Alexander, M; Burroughs, L; Clark, EA; F Trindade, G; Hague, R; He, Y; Irvine, DJ; Roberts, CJ; Rose, FRAJ; Ruiz-Cantu, L; Taresco, V; Tuck, C; Wildman, RD; Zhou, Z | 1 |
| Garaev, GSh; Kurbanov, IaZ; Mamedov, IaD; Mirza-zade, AA; Nasibzade, AA | 1 |
2 other study(ies) available for n-vinyl-2-pyrrolidinone and Coronary Disease
| Article | Year |
|---|---|
Bespoke 3D-Printed Polydrug Implants Created via Microstructural Control of Oligomers.
Topics: Antihypertensive Agents; Coronary Disease; Dioxanes; Drug Carriers; Drug Compounding; Drug Liberation; Excipients; Humans; Indoles; Methacrylates; Phase Transition; Polyesters; Polymers; Printing, Three-Dimensional; Pyrrolidinones; Structure-Activity Relationship | 2021 |
[Effect of lymph-stimulating drugs on the clinical manifestations and parameters of lipid metabolism in patients with post-infarction cardiosclerosis and angina pectoris].
Topics: Adult; Aged; Angina Pectoris; Coronary Disease; Dextrans; Drug Combinations; Humans; Hyperlipidemias; Lipid Peroxidation; Lymphatic System; Mannitol; Middle Aged; Myocardial Infarction; Myocardium; Povidone; Sclerosis | 1991 |